Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
The concept of innovative drugs is repeatedly active, with multiple stocks including Menovah hitting the daily limit.
Mars Finance News, March 30 - The innovative drug concept has been repeatedly active, with Minohua achieving 7 days of 6 limit-ups. Wanbangde, Shuanglu Pharmaceutical, and Dongcheng Pharmaceutical have also hit the daily limit, while Lianhuan Pharmaceutical, Hite Biological, Shutaishen, and Hongbo Pharmaceutical have followed suit. On the news front, Eli Lilly and Insilico Medicine have reached an agreement worth $2.75 billion, planning to launch the drugs developed by the latter using artificial intelligence into the global market. According to the announcement, this agreement will provide Insilico Medicine with a $115 million upfront payment, with the remaining amount to be paid based on regulatory and commercial milestones as well as royalties on future sales. (Ke Gu Bao Report)